Eric K. Singhi: Isn’t it about time we stopped saying that “patients failed treatment”
Eric K. Singhi reshared his previous post on X and added: ;
“But also…isn’t it about time we stopped saying that ‘patients failed treatment’.
The treatment failed the patient, NOT the other way around. Words matter. ”
Quoting the previous post:
“HARMONi-A: Phase 3 Ivonescimab + chemo v chemo alone in patients with EGFR+ mNSCLC s/p 1L EGFR-TKI
- Anti-PD-1/VEGF bispecific Ab
- 322 patients
- PFS 7 months v 4.8 months (HR 0.46)
- ORR 51% v 35%
Where will this drug fit in our evolving 2L+ landscape for patients?”
Source: Eric K. Singhi/X
Eric K. Singhi is a thoracic and head and neck medical oncologist, currently serving as an Assistant Professor in the Department of General Oncology within the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston, TX.
Dr. Singhi is highly skilled in general internal medicine and hematology/oncology, with a special focus on thoracic medical oncology. Fluent in multiple languages, including Hindi and Spanish, he is dedicated to providing personalized care and improving patient outcomes.
Dr. Singhi’s interests extend to patient education, patient-reported outcomes, and community outreach. He is affiliated with various hospitals in the Houston area, including Harris Health Ben Taub General and LBJ Hospitals, and The University of Texas MD Anderson Cancer Center.
With over 6-10 years of experience, Dr. Eric K. Singhi is committed to delivering exceptional care to his patients and advancing the field of oncology.
